Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?

Bibliographic Details
Title: Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?
Authors: Raiser, Patricia, Schleiermacher, Gudrun, Gambart, Marion, Dumont, Benoit, Defachelles, Anne-Sophie, Thebaud, Estelle, Tandonnet, Julie, Pasqualini, Claudia, Proust, Stéphanie, Entz-Werle, Natacha, Aerts, Isabelle, Ndounga-Diakou, Lee A., Petit, Arnaud, Puiseux, Chloe, Khanfar, Camille, Rouger, Jeremie, Mansuy, Ludovic, Benadiba, Joy, Millot, Frédéric, Pluchart, Claire, Laghouati, Salim, Geoerger, Birgit, Vassal, Gilles, Valteau-Couanet, Dominique, Berlanga, Pablo
Source: In European Journal of Cancer May 2024 202
Database: ScienceDirect
More Details
ISSN:09598049
DOI:10.1016/j.ejca.2024.114001
Published in:European Journal of Cancer
Language:English